MTOR and ovarian cancer: Eclalbasaponin II has the ability to arrest cell cycle in the G1 phase, induced apoptosis and cell death through autophagy by regulating the JNK, p38, and mTOR signaling pathways in SKOV3 and A2780 human ovarian cancer cells.